According
to a new market report published by Transparency Market Research
Ophthalmic Drugs Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2013 - 2018, the global ophthalmic drugs
market was valued at USD 16 billion in 2012 and is expected to grow
at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of
USD 21.6 billion in 2018.
Globally,
the ophthalmic drugs market is witnessing significant growth due to
increasing prevalence of eye disorders such as diabetic retinopathy
and macular degeneration. As a result, this market is expected to
grow at a CAGR of about 5.2% during 2013 – 2018.
Browse
the full Ophthalmic Drugs Market report at
http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html
Some
of the key driving factors for the ophthalmic drugs market are rising
prevalence of global aging population, increasing government
initiatives towards healthcare infrastructure in developing countries
(such as India and China), technological changes in drug delivery
technique, and increasing prevalence of lifestyle associated
diseases. However, the market faces some restraints such as lack of
awareness among people regarding eye disorders, drying pipeline of
ophthalmic drugs, patent expiration of blockbuster ophthalmic drugs
and absence of health insurance in developing countries.
North
America, including the US has the largest ophthalmic drugs market.
Asia is the fastest growing ophthalmic drugs market. Some of the
fastest growing markets for ophthalmic drugs are China, India, other
countries in South East Asia and the Eastern Mediterranean. As per
WHO estimates in 2010, in the next nine years, the number of blind
people aged 50 years and above will grow in these regions, thereby
increasing the demand for ophthalmic drugs. On the other hand, in
developed regions such as North America and Western Europe, rising
efforts towards prevention of blindness among the aging population
has emerged as a key driver for the market.
Glaucoma
has the largest market share in the ophthalmic drugs market and it is
expected to grow at a CAGR of about 4.2% during 2013 – 2018.
Various ophthalmic drug companies are increasing their focus on
combination therapy, which involves use of more than one medication
for specific retinal disorders. Most of these combination therapies
are used as first line treatment in patients with high level of
intraocular pressure. Combination therapy has various advantages over
traditional medication such as reduced frequency of eye drop
application, improved patient compliance and efficacy.
Browse
the full Press Release :
http://www.transparencymarketresearch.com/pressrelease/ophthalmic-drugs-market.htm
Novartis
(Alcon) is the leading player in the global ophthalmic drugs market
with a share of about 24% in 2012. Other major players of ophthalmic
drugs
market
include Allergan, Santen, Pfizer, Merck and Roche and others.
The
global ophthalmic drugs market is segmented as follows:
Ophthalmic
Drugs Market, By Treatment Drugs
Dry
Eye Drugs
Retinal
Drugs
Anti-inflammatory/allergy/infective
Drugs
Anti-glaucoma
Drugs
Ophthalmic
Drugs Market, By Types
Prescription
Drugs
OTC
Drugs
Ophthalmic
Drugs Market, by Geography
North
America
U.S.
Europe
Germany
U.K.
France
Asia
Pacific
Japan
China
India
Rest
of the World (RoW)
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1769
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants, use
proprietary data sources and various tools and techniques to gather,
and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Mr.Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com/
No comments:
Post a Comment